FDA Approves IV Version Of Smallpox Drug As Monkeypox Emerges

By Beth Wang / May 20, 2022 at 7:01 PM
FDA on Thursday (May 19) approved an intravenous version of SIGA Technologies’ smallpox drug TPOXX (tecovirimat), coming as cases of monkeypox -- which is in the same viral family as smallpox -- emerge around the world and in the United States. TPOXX is not FDA-approved to treat monkeypox, but a company official told Inside Health Policy it has been shown to work against the disease. There is no FDA-approved treatment for monkeypox, but there are currently two FDA-approved drugs...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.